DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Viramune (Nevirapine) - Hospitalization - Suspected Cause - Side Effect Reports

 
 



Index of reports > Hospitalization (52)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Viramune (Nevirapine) hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 52   Next >>

Possible Viramune side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23

Patient:

Reactions: Cholestasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epivir
    Dosage: 150 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-22
    End date: 2012-06-12

Isentress
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-22
    End date: 2012-06-12

Viramune
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-22
    End date: 2012-06-12



Possible Viramune side effects in male

Reported by a physician from France on 2012-08-20

Patient: male

Reactions: Pruritus, Malaise, Rash Generalised, Hepatocellular Injury, Cholestasis, Chromaturia, Faeces Discoloured

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epivir
    Dosage: 150mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-22
    End date: 2012-06-12

Isentress
    Dosage: 400mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-22
    End date: 2012-06-12

Viramune
    Dosage: 200mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-22
    End date: 2012-06-12



Possible Viramune side effects in male

Reported by a physician from France on 2012-08-16

Patient: male

Reactions: Agitation, Urinary Incontinence, Coma, Coma Scale Abnormal, Pyrexia, Hepatotoxicity, Eye Movement Disorder, Hepatosplenomegaly, Anaemia, Malnutrition, General Physical Health Deterioration, Encephalopathy, Faecal Incontinence, Convulsion, Respiratory Tract Congestion, Apathy, Depressed Level of Consciousness, Nervous System Disorder, Confusional State, Immune Reconstitution Syndrome, Snoring, Hepatitis Cholestatic, Intracranial Pressure Increased, Hepatic Ischaemia, Thrombocytopenia, Oxygen Saturation Decreased, Refusal of Treatment by Patient, Necrotising Granulomatous Lymphadenitis, Hepatic Fibrosis, Mycobacterial Infection, Hyponatraemia, Cerebral Atrophy, White Blood Cell Disorder, Renal Failure, Hypoproteinaemia, Diarrhoea, Brain Abscess, Heart Rate Increased, Encephalitic Infection, Heart Sounds Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Dosage: df 10mg/ml
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Amikacin
    Dosage: 900 mg daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Bactrim
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Cernevit-12
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Clarithromycin
    Dosage: df 50mg/ml
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Folic Acid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-01

Kaletra
    Dosage: df 80/20 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Myambutol
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Nefopam
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Olanzapine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-01

Perikabiven (Parenteral Nutrition)
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Potassium Chloride
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Prazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Rifabutin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Viramune
    Indication: HIV Infection
    Start date: 2012-03-01
    End date: 2012-05-01

Other drugs received by patient: Propofol; Adavat



Possible Viramune side effects in male

Reported by a physician from France on 2012-08-15

Patient: male

Reactions: Agitation, Urinary Incontinence, Coma, Pyrexia, Coma Scale Abnormal, Hepatotoxicity, Eye Movement Disorder, Hepatosplenomegaly, Anaemia, Malnutrition, Encephalopathy, Faecal Incontinence, General Physical Health Deterioration, Convulsion, Apathy, Respiratory Tract Congestion, Depressed Level of Consciousness, Nervous System Disorder, Confusional State, Immune Reconstitution Syndrome, Snoring, Hepatitis Cholestatic, Intracranial Pressure Increased, Hepatic Ischaemia, Thrombocytopenia, Oxygen Saturation Decreased, Refusal of Treatment by Patient, Necrotising Granulomatous Lymphadenitis, Hepatic Fibrosis, Mycobacterial Infection, Cerebral Atrophy, Hyponatraemia, Renal Failure, White Blood Cell Disorder, Diarrhoea, Hypoproteinaemia, Heart Rate Increased, Brain Abscess, Encephalitic Infection, Heart Sounds Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Dosage: df 10mg/ml
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Amikacin
    Dosage: 900 mg daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Bactrim
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Cernevit-12
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Clarithromycin
    Dosage: df 50mg/ml
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Folic Acid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-01

Kaletra
    Dosage: df 80/20 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Myambutol
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Nefopam
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Olanzapine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-01

Perikabiven (Parenteral Nutrition)
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Potassium Chloride
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Prazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Rifabutin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Viramune
    Indication: HIV Infection
    Start date: 2012-03-01
    End date: 2012-05-01

Other drugs received by patient: Adavat; Propofol



Possible Viramune side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-15

Patient: male

Reactions: Cholestasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epivir
    Dosage: 150 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-22
    End date: 2012-06-12

Isentress
    Dosage: 800 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-22
    End date: 2012-06-12

Viramune
    Dosage: 400 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-22
    End date: 2012-06-12



Possible Viramune side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-03

Patient: 52 year old female

Reactions: Hypersensitivity, Rash Generalised, Glomerular Filtration Rate Decreased, Alanine Aminotransferase Increased, Pyrexia, Myalgia, Malaise, Arthralgia, Liver Function Test Abnormal, Blood Creatinine Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Viramune

Other drugs received by patient: Abacavir Sulfate / Lamivudine



Possible Viramune side effects in male

Reported by a physician from South Africa on 2012-07-31

Patient: male, weighing 2.9 kg (6.3 pounds)

Reactions: Rectal Haemorrhage, Neonatal Asphyxia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Viramune
    Indication: Prophylaxis Against HIV Infection
    Start date: 2012-06-25
    End date: 2012-06-25

Viramune
    Dosage: 1.5 ml
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 2012-06-26

Other drugs received by patient: Emtricitabine / Tenofovir Disoproxil Fumarate; Zidovudine



Possible Viramune side effects in male

Reported by a physician from Germany on 2012-07-27

Patient: male, weighing 60.0 kg (132.0 pounds)

Reactions: Abdominal Discomfort, Malaise, Nausea, Angina Pectoris, Hypotension, Suicide Attempt, Pyrexia, Rash, Blood Creatinine Increased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ibuprofen
    Dosage: 20 anz
    Administration route: Oral

Viramune
    Dosage: 40 anz
    Administration route: Oral



Possible Viramune side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-27

Patient: female

Reactions: Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Truvada
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-21
    End date: 2012-02-13

Viramune
    Dosage: unk
    Administration route: Oral
    Start date: 2012-01-21
    End date: 2012-02-04

Viramune
    Dosage: 2 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-02-05
    End date: 2012-02-13

Other drugs received by patient: Kaletra; Viread



Possible Viramune side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient: female

Reactions: Mouth Ulceration, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Truvada
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-01-01
    End date: 2012-05-07

Viramune
    Dosage: 1 df, qd
    Administration route: Oral
    Start date: 2012-04-10
    End date: 2012-04-25

Viramune
    Dosage: 2 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-04-26
    End date: 2012-05-07

Other drugs received by patient: Norvir; Reyataz



Possible Viramune side effects in male

Reported by a physician from South Africa on 2012-07-24

Patient: male, weighing 2.9 kg (6.3 pounds)

Reactions: Rectal Haemorrhage, Neonatal Asphyxia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Viramune
    Dosage: 1.5 ml
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 2012-06-26

Viramune
    Indication: Prophylaxis Against HIV Infection
    Start date: 2012-06-25
    End date: 2012-06-25

Other drugs received by patient: Emtricitabine / Tenofovir Disoproxil Fumarate; Zidovudine



Possible Viramune side effects in male

Reported by a physician from South Africa on 2012-07-20

Patient: male, weighing 2.9 kg (6.3 pounds)

Reactions: Rectal Haemorrhage, Neonatal Asphyxia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Viramune
    Dosage: 1.5 ml
    Administration route: Oral
    Indication: Prophylaxis Against HIV Infection
    Start date: 2012-06-26

Viramune
    Indication: Prophylaxis Against HIV Infection
    Start date: 2012-06-25
    End date: 2012-06-25

Other drugs received by patient: Zidovudine; Emtricitabine / Tenofovir Disoproxil Fumarate



Possible Viramune side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-20

Patient: female

Reactions: Lipodystrophy Acquired

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-03-04

Viramune
    Dosage: 400 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-15



Possible Viramune side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-18

Patient: female

Reactions: Lipodystrophy Acquired

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Truvada
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-03-04

Viramune
    Dosage: 2 df, unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2005-03-15



Possible Viramune side effects in male

Reported by a physician from Germany on 2012-07-10

Patient: male

Reactions: Nausea, Angina Pectoris, Hypotension, Rash, Pyrexia, Abdominal Discomfort, Malaise, Suicide Attempt, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ibuprofen
    Dosage: unkown amount
    Administration route: Oral

Viramune
    Dosage: 40 anz
    Administration route: Oral



Possible Viramune side effects in 60 year old male

Reported by a physician from Netherlands on 2012-07-05

Patient: 60 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Angioedema, Dyspnoea, Swollen Tongue

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Viramune

Other drugs received by patient: ACE-Inhibitor



Possible Viramune side effects in 28 year old female

Reported by a physician from United Kingdom on 2012-06-21

Patient: 28 year old female, weighing 54.2 kg (119.2 pounds)

Reactions: CD4 Lymphocytes Decreased, Hypersensitivity, Pyrexia, Rash, Constipation, Hepatic Enzyme Increased, Myalgia, Fatigue

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Viramune

Other drugs received by patient: Truvada; Kaletra; Cyclizine



Possible Viramune side effects in 28 year old female

Reported by a physician from United Kingdom on 2012-06-11

Patient: 28 year old female

Reactions: Hypersensitivity, Pyrexia, Rash, Constipation, Hepatic Enzyme Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Viramune

Other drugs received by patient: Truvada



Possible Viramune side effects in

Reported by a physician from United States on 2012-06-08

Patient:

Reactions: Pancreatitis Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Viramune

Viramune
    Indication: HIV Infection



Possible Viramune side effects in 41 year old male

Reported by a physician from United Kingdom on 2012-06-05

Patient: 41 year old male, weighing 62.5 kg (137.5 pounds)

Reactions: Rash Generalised, Vomiting, Swelling Face, Mouth Ulceration, Tachycardia, Pyrexia, Plantar Fasciitis, Diarrhoea, Paraneoplastic Pemphigus, Abdominal Distension, Treponema Test Positive, Lymphoma, Stevens-Johnson Syndrome

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Viramune

Other drugs received by patient: Antobiotics; Lots OF Medications



Possible Viramune side effects in 38 year old female

Reported by a pharmacist from United Kingdom on 2012-06-05

Patient: 38 year old female

Reactions: Maternal Exposure During Pregnancy, Anaemia Haemolytic Autoimmune

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kyvexa
    Dosage: 1 anz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-10-01
    End date: 2012-04-28

Viramune
    Dosage: 400 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-15
    End date: 2012-04-28

Other drugs received by patient: Folic Acid; Iron; Calceos



Possible Viramune side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-18

Patient: female

Reactions: Rash, Pyrexia, Leukopenia, Hypertransaminasaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Viramune

Other drugs received by patient: Truvada; Acetylcysteine; Augmentin



Possible Viramune side effects in 38 year old female

Reported by a pharmacist from United Kingdom on 2012-05-08

Patient: 38 year old female

Reactions: Maternal Exposure During Pregnancy, Anaemia Haemolytic Autoimmune, Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kyvexa
    Dosage: 1 anz
    Indication: HIV Infection

Viramune
    Dosage: 400 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-15
    End date: 2012-04-28

Other drugs received by patient: Caseos; Iron; Folic Acid



Possible Viramune side effects in 29 year old male

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-04-25

Patient: 29 year old male

Reactions: Migraine, Rash Generalised, Ear Pain, Headache, Pyrexia, Erythema, Toxic Skin Eruption, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Augmentin XR
    Dosage: 1000 / 62.5 mg
    Administration route: Oral
    Indication: Bacterial Infection
    Start date: 2009-04-16
    End date: 2009-04-20

Emtricitabine and Tenofovir Disoproxil Fumarate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-04-14
    End date: 2009-04-24

Ibuprofen
    Administration route: Oral
    Indication: Pain
    Start date: 2009-04-16
    End date: 2009-04-20

Viramune
    Administration route: Oral
    Indication: Asymptomatic HIV Infection
    Start date: 2009-04-14
    End date: 2009-04-24



Possible Viramune side effects in 35 year old female

Reported by a physician from Switzerland on 2012-04-25

Patient: 35 year old female

Reactions: Pruritus, Nausea, Pain in Extremity, Headache, Rash, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms, Transaminases Increased, Fatigue, Hepatocellular Injury

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra
    Dosage: 3 in 1 d, dose schema 1-0-2
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-01
    End date: 2012-02-09

Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-01
    End date: 2012-02-07



Possible Viramune side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-04-23

Patient: 40 year old female

Reactions: Jaundice, Hepatic Encephalopathy, Vomiting, Nausea, Oliguria, Coagulopathy, Hypoglycaemia, Acute Hepatic Failure, Pyrexia, Decreased Appetite

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-02-01
    End date: 2010-07-29

Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-01
    End date: 2010-07-29

Other drugs received by patient: Alprazolam; Zolpidem Tartrate; Temazepam; Atarax



Possible Viramune side effects in male

Reported by a physician from Austria on 2012-04-20

Patient: male

Reactions: Vomiting, Diarrhoea, Anaemia, Urinary Tract Infection, Pulmonary Embolism, Pyrexia, Melaena

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Marcumar
    Administration route: Oral
    Indication: Pulmonary Embolism
    Start date: 2009-09-29

Viramune
    Dosage: 400 mg
    Administration route: Oral
    Start date: 2009-11-02

Viramune
    Dosage: 400 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-10-13

Other drugs received by patient: Truvada



Possible Viramune side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-04-13

Patient: 40 year old female

Reactions: Jaundice, Vomiting, Nausea, Coagulopathy, Hypoglycaemia, Pyrexia, Hepatic Encephalopathy, Oliguria, Acute Hepatic Failure, Decreased Appetite

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-02-01
    End date: 2010-07-29

Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-01
    End date: 2010-07-29

Other drugs received by patient: Atarax; Temazepam; Zolpidem Tartrate; Alprazolam



Possible Viramune side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-12

Patient: male

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Viramune



Possible Viramune side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-10

Patient: male

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Viramune



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012